Advertisement
Home »

Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial.

May 01, 2023

ABOUT THE EXPERTS

  • Petros Grivas

    Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA. Electronic address: pgrivas@uw.edu.

    Se Hoon Park

    Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

    Eric Voog

    Centre Jean Bernard Clinique Victor Hugo, Le Mans, France.

    Claudia Caserta

    Medical Oncology Unit, Azienda Ospedaliera S. Maria, Terni, Italy.

    Howard Gurney

    Department of Clinical Medicine, Macquarie University, Sydney, Australia.

    Joaquim Bellmunt

    Department of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

    Haralabos Kalofonos

    Medical Oncology, University General Hospital of Patras, Patras, Greece.

    Anders Ullén

    Department of Pelvic Cancer, Genitourinary Oncology Unit, Karolinska University Hospital, Solna, Sweden.

    Yohann Loriot

    INSERM U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France.

    Srikala S Sridhar

    Princess Margaret Cancer Center, University Health Network, Toronto, Canada.

    Yoshiaki Yamamoto

    Yamaguchi University Hospital, Ube, Yamaguchi, Japan.

    Daniel P Petrylak

    Yale Cancer Center, New Haven, CT, USA.

    Cora N Sternberg

    Weill Cornell Medicine, Hematology/Oncology, Englander Institute for Precision Medicine, Meyer Cancer Center, New York, NY, USA.

    Shilpa Gupta

    Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

    Bo Huang

    Pfizer, Groton, CT, USA.

    Nuno Costa

    Pfizer, Porto Salvo, Portugal.

    Robert J Laliberte

    Pfizer, Cambridge, MA, USA.

    Alessandra di Pietro

    Pfizer srl, Milano, Italy.

    Begoña P Valderrama

    Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.

    Thomas Powles

    Barts Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London, St. Bartholomew’s Hospital, London, UK.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement